Zobrazeno 1 - 10
of 95
pro vyhledávání: '"Aravind Krishnan"'
Autor:
Aravind Krishnan, MD, Alex R. Dalal, MD, Albert James Pedroza, MD, Ken Nakamura, MD, Nobu Yokoyama, MD, Emily Tognozzi, PA-C, Y. Joseph Woo, MD, Michael Fischbein, MD PhD, John Ward MacArthur, MD
Publikováno v:
JTCVS Open, Vol 13, Iss , Pp 1-8 (2023)
Background: Contemporary series of aortic arch replacement at the time of aortic root surgery are limited in number of patients and mostly address hemiarch replacement. We describe outcomes after aortic root and concomitant arch replacement, includin
Externí odkaz:
https://doaj.org/article/156ba3c398f0479da0dd38e92872bfe1
Autor:
Alex R. Dalal, MD, Albert J. Pedroza, MD, Aravind Krishnan, MD, Yan Min, MD, MS, Emily Tognozzi, PA-C, Nobu Yokoyama, MD, Ken Nakamura, MD, Olivia R. Mitchel, BS, Michael Baiocchi, PhD, Y. Joseph Woo, MD, John W. MacArthur, MD, Michael P. Fischbein, MD, PhD
Publikováno v:
JTCVS Open, Vol 13, Iss , Pp 9-19 (2023)
Objective: To evaluate the effect of perioperative allogeneic packed red blood cell (RBC) transfusion during aortic root replacement. Method: We reviewed patients undergoing aortic root replacement at our institution between March 2014 and April 2020
Externí odkaz:
https://doaj.org/article/07327f7dcdd3474bb97c01fa04c96be2
Publikováno v:
The Lancet Regional Health - Southeast Asia, Vol 17, Iss , Pp 100273- (2023)
Externí odkaz:
https://doaj.org/article/09c54973df4843a89af50467e3b7b56c
Autor:
Hanjay Wang, MD, Simar S. Bajaj, Joseph C. Heiler, MD, Aravind Krishnan, MD, Kiah M. Williams, MD, Y. Joseph Woo, MD, Jack H. Boyd, MD
Publikováno v:
JTCVS Open, Vol 9, Iss , Pp 162-175 (2022)
Objectives: Cardiothoracic (CT) surgeons with National Institutes of Health (NIH) R01 funding face a highly competitive renewal process. The factors that contribute to successful grant renewal for CT surgeons remain poorly defined. We hypothesized th
Externí odkaz:
https://doaj.org/article/6566c627e5964e27b743edddeb45f9e1
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 10 (2022)
Ischemic heart disease is the leading cause of death around the world, and though the advent of coronary revascularization has revolutionized its treatment, many patients who sustain ischemic injury to the heart will go on to develop heart failure. B
Externí odkaz:
https://doaj.org/article/721e0b1d7b864fb2b58a4dcef181b405
Publikováno v:
In Materials Today: Proceedings 2022 65 Part 2:1105-1111
Autor:
Ananth V. Charya, Ileana L. Ponor, Adam Cochrane, Deborah Levine, Mary Philogene, Yi-Ping Fu, Moon K. Jang, Hyesik Kong, Pali Shah, Ann Mary Bon, Aravind Krishnan, Joby Mathew, Helen Luikart, Kiran K. Khush, Gerald Berry, Charles Marboe, Aldo Iacono, Jonathan B. Orens, Steven D. Nathan, Sean Agbor-Enoh
Publikováno v:
The Journal of Heart and Lung Transplantation. 42:226-235
Pulmonary antibody-mediated rejection (AMR) consensus criteria categorize AMR by diagnostic certainty. This study aims to define the clinical features and associated outcomes of these recently defined AMR categories.Adjudication committees reviewed c
Autor:
Hanjay Wang, Simar S. Bajaj, Kiah M. Williams, Christian T. O'Donnell, Joseph C. Heiler, Aravind Krishnan, Joshua M. Pickering, Mark Sanchez, Keerthi Manjunatha, Sean S. Kumar, Maggie M. Yu, Jack H. Boyd
Publikováno v:
Journal of Surgical Research. 275:265-272
The National Institutes of Health (NIH) recently developed the relative citation ratio (RCR), calculated as article citations benchmarked to NIH-funded publications in the same field. Here, we characterized the scholarly impact of academic cardiothor
Autor:
Benjamin L. Shou, Christopher Wilcox, Isabella Florissi, Aravind Krishnan, Bo Soo Kim, Steven P. Keller, Glenn J.R. Whitman, Ken Uchino, Errol L. Bush, Sung-Min Cho
Publikováno v:
Chest.
Autor:
Dayanand Vinod, Aravind Krishnan
Publikováno v:
Current Computer-Aided Drug Design. 19
Background:: There has been a growing interest in discovering a viable drug for the new coronavirus (SARS-CoV-2) since the beginning of the pandemic. Protein-ligand interaction studies are a crucial step in the drug discovery process, as it helps us